| Patient‐based prediction algorithm of relapse after allo‐HSCT for acute Leukemia and its usefulness in the decision‐making process using a machine learning approach K Fuse, S Uemura, S Tamura, T Suwabe, T Katagiri, T Tanaka, T Ushiki, ... Cancer medicine 8 (11), 5058-5067, 2019 | 30 | 2019 |
| Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis T Katagiri, S Uemura, T Ushiki, Y Nakajima-Takagi, M Oshima, T Mikami, ... Experimental hematology 96, 52-62. e5, 2021 | 13 | 2021 |
| A simple and highly efficient method to identify the integration site of a transgene in the animal genome S Uemura, T Nagaoka, M Yokoyama, M Igarashi, M Kishi Neuroscience research 80, 91-94, 2014 | 9 | 2014 |
| Successful treatment with edoxaban for disseminated intravascular coagulation in a case of aortic dissection complicated with immune thrombocytopenic purpura S Uemura, H Kobayashi, Y Seki, Y Okoshi, H Sone, N Nomoto Internal Medicine 59 (16), 2035-2039, 2020 | 5 | 2020 |
| YAP1/TAZ activity maintains vascular integrity and organismal survival S Uemura, M Yamashita, K Aoyama, T Yokomizo-Nakano, M Oshima, ... Biochemical and Biophysical Research Communications 619, 117-123, 2022 | 4 | 2022 |
| Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis Y Nakajima-Takagi, M Oshima, J Takano, S Koide, N Itokawa, S Uemura, ... Elife 12, e83004, 2023 | 2 | 2023 |
| Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells MSJ Lee, J Matsuo-Dapaah, C Del Rosario Zorrilla, Y Omatsu, ... International Immunology, dxae012, 2024 | 1 | 2024 |
| Heterogeneity of intrahepatic iron deposition in transfusion-dependent iron overload patients with hematological malignancies H Kobayashi, N Yoshimura, S Uemura, T Katagiri, T Tanaka, T Ushiki, ... Leukemia research 70, 41-44, 2018 | 1 | 2018 |
| Peripheral T-cell lymphoma, not otherwise specified: a retrospective single-center analysis. T Suzuki, K Kawamoto, S Tamura, S Uemura, A Kaihatsu, H Nemoto, ... [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 58 (8), 905-911, 2017 | 1 | 2017 |
| 2003–PHARMACOLOGICAL BOOSTING OF YAP/TAZ ACTIVITY IN THE BONE MARROW NICHE ACCELERATES HEMATOPOIETIC REGENERATION S Uemura, M Yamashita, T Yokomizo-Nakano, Y Yamada, A Aihara, ... Experimental Hematology 124, S38, 2023 | | 2023 |
| YAP/TAZ Promote Hematopoietic Regeneration Via Accelerating the Recovery of Bone Marrow Niche S Uemura, M Yamashita, A Aihara, T Iwawaki, S Koide, ... Blood 138, 199, 2021 | | 2021 |
| PS1050 MARKER CHROMOSOME IS A STRONG POOR PROGNOSIS FACTOR AFTER ALLOGENEIC HSCT FOR AML PATIENTS K Fuse, T Tanaka, S Uemura, S Tamura, T Suwabe, T Katagiri, T Ushiki, ... HemaSphere 3 (S1), 475, 2019 | | 2019 |
| MARKER CHROMOSOME IS A STRONG POOR PROGNOSIS FACTOR AFTER ALLOGENEIC HSCT FOR AML PATIENTS: PS1050 K Fuse, T Tanaka, S Uemura, S Tamura, T Suwabe, T Katagiri, T Ushiki, ... Hemasphere 3, 2019 | | 2019 |
| Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT K Fuse, T Tanaka, S Uemura, T Suwabe, T Katagiri, T Ushiki, Y Shibasaki, ... Blood 132, 5260, 2018 | | 2018 |
| Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach K Fuse, S Uemura, T Suwabe, T Katagiri, T Tanaka, T Ushiki, Y Shibasaki, ... Blood 130, 2044, 2017 | | 2017 |
| Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT Y Shibasaki, T Suwabe, S Uemura, T Katagiri, T Tanaka, T Ushiki, K Fuse, ... Blood 130, 4590, 2017 | | 2017 |
